Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
TAK-285
CHF 0.00
In stock
SYN-1153-M0011 mgCHF 234.00
SYN-1153-M0055 mgCHF 369.00
SYN-1153-M01010 mgCHF 646.00
SYN-1153-M05050 mgINQ
SYN-1153-M100100 mgINQ
| Product Details | |
|---|---|
| Synonyms | TAK285 |
| Product Type | Chemical |
| Properties | |
| Formula | C26H25ClF3N5O3 |
| MW | 548.0 |
| CAS | 871026-44-7 |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO or ethanol. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data |
Target: EGFR - HER2 | Kinase Group: RTK | Substrate: Tyrosine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
| InChi Key | ZYQXEVJIFYIBHZ-UHFFFAOYSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
TAK-285 is a novel investigational dual HER2/EGFR inhibitor with IC(50) values of 17 and 23nM, respectively.
Product References
- Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold: T. Ishikawa, et al.; J. Med. Chem. 54, 8030 (2011)
Related Products
